1. Home
  2. CRESY vs HELP Comparison

CRESY vs HELP Comparison

Compare CRESY & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cresud S.A.C.I.F. y A.

CRESY

Cresud S.A.C.I.F. y A.

SELL

Current Price

$10.74

Market Cap

804.3M

Sector

Finance

ML Signal

SELL

Logo Cybin Inc. Common Stock

HELP

Cybin Inc. Common Stock

HOLD

Current Price

$10.47

Market Cap

862.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRESY
HELP
Founded
1936
2019
Country
Argentina
Canada
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
804.3M
862.2M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
CRESY
HELP
Price
$10.74
$10.47
Analyst Decision
Buy
Strong Buy
Analyst Count
2
11
Target Price
$15.86
★ $41.40
AVG Volume (30 Days)
206.5K
★ 1.3M
Earning Date
11-09-2026
11-12-2026
Dividend Yield
★ 5.32%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.96
N/A
Revenue Next Year
$19.02
N/A
P/E Ratio
$6.92
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.26
$3.76
52 Week High
$14.21
$15.15

Technical Indicators

Market Signals
Indicator
CRESY
HELP
Relative Strength Index (RSI) 38.74 43.27
Support Level $10.52 $9.97
Resistance Level $11.74 $14.75
Average True Range (ATR) 0.42 0.93
MACD -0.07 -0.05
Stochastic Oscillator 19.21 21.68

Price Performance

Historical Comparison
CRESY
HELP

About CRESY Cresud S.A.C.I.F. y A.

Cresud SACIF y A is a Latin American agricultural firm producing basic commodities with a growing presence in Argentina, Brazil, and other countries through its investment in Brasilagro. It focuses on grains, sugarcane, and cattle farming, acquiring and developing agricultural properties for production or value appreciation, and occasionally selling appreciated land. It also leases land and offers agency and agro-industrial services. Operations are divided into two segments: agricultural business (production, land transformation and sales, corporate services) and urban properties and investments (shopping malls, offices, sales, developments, hotels, and related activities).

About HELP Cybin Inc. Common Stock

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.

Share on Social Networks: